Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial

Documenti analoghi

• How should respiratory depression and loss of airway patency be handled during initiation of palliative sedation?
  di: Olav Magnus S. Fredheim, et al.
  Pubblicazione: (2024)
• Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus
  di: Chih‐Jia Chao, et al.
  Pubblicazione: (2024)
• Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial
  di: Alexander Hincker, et al.
  Pubblicazione: (2024)
• Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self‐administration and relapse in mice
  di: Idaira Oliva, et al.
  Pubblicazione: (2024)
• Pelvic floor symptoms according to the severity of second‐degree perineal tears within 12 months post‐partum: A longitudinal prospective cohort study
  di: Marthe Dalevoll Macedo, et al.
  Pubblicazione: (2024)